For North or South America, or China/Japan/Korea visit our collaborators SECURE-cirrhosis.
or read on for more information
COVID-Hep.net: Coronavirus (COVID-19) in liver disease reporting registry
The advent and pandemic spread of the novel coronavirus SARS-CoV2, and its associated disease state COVID-19, is a major and developing international public health emergency. The spectrum of disease and factors that influence the disease course are incompletely defined.
We have established this universal and collaborative registry project to collect data on patients with liver disease at any stage or liver transplants who develop laboratory-confirmed COVID-19. We are pleased to encourage reports from worldwide. However, if reporting from the Americas or China/Japan/Korea, please see our collaborators at: SECURE-cirrhosis.
We wish to capture pre-cirrhotic patients, immunosuppressed liver patients, both compensated and decompensated cirrhotic patients, and those that have already been transplanted. We intend to capture data both for patients who are hospitalised or managed in the community.
Reporting a case takes around 5 minutes. We will be pleased to acknowledge all those who contribute in any publication and we intend to invite major contributors to join our authorship.